What is Bloom Science?
Founded in 2017, Bloom Science is at the forefront of developing novel microbiome therapeutics and drugs. The company leverages cutting-edge scientific research to address unmet medical needs, positioning itself as a key player in the rapidly evolving field of gut health and its impact on systemic diseases. Their focus on the microbiome signifies a strategic bet on a complex biological system with vast therapeutic potential.
How much funding has Bloom Science raised?
Bloom Science has raised a total of $12.1M across 2 funding rounds:
Debt
$95K
Series A
$12M
Debt (2021): $95K with participation from PPP
Series A (2021): $12M led by Joyance Partners, Bayer, Apollo Health Ventures, and ALS Investment Fund
Key Investors in Bloom Science
Joyance Partners
Joyance Partners is a venture capital firm that invests in companies leveraging science and technology to enhance quality of life, with a focus on health and consumer sectors from pre-seed to Series A. They are interested in personal health, beauty, food and drink, techbio, and sustainability.
Bayer
Bayer is a global enterprise focused on life sciences, particularly in healthcare and nutrition, aiming to support global population health challenges with its pharmaceutical, crop science, animal health, and consumer health divisions.
Apollo Health Ventures
Apollo Health Ventures is an early-stage venture capital firm specializing in transformative healthcare companies that address age-related diseases and aging, aiming to enhance healthy lifespan through biotechnology innovations.
What's next for Bloom Science?
The recent major strategic investment signals a pivotal growth phase for Bloom Science. This capital infusion is expected to accelerate the company's research and development efforts, potentially enabling clinical trials and further pipeline expansion. The backing from prominent investors suggests confidence in Bloom Science's technology and its potential to disrupt the pharmaceutical landscape. Future endeavors will likely focus on translating scientific discoveries into viable therapeutic solutions and navigating the complex regulatory pathways for drug approval.
See full Bloom Science company page
